Mui Kow - Haw Par Executive
| HAWPY Stock | USD 28.64 0.00 0.00% |
Executive
Mr. Kow Mui Lick is Senior Manager Quality Regulatory Affairs of Healthcare of Haw Par Corporation Ltd. He joined Haw Par Healthcare in 1991 as QCLaboratory Manager and promoted to Senior Manager in 2007. Appointed to present position in 2011. Holds a BS from the University of Singapore.
| Phone | 65 6337 9102 |
| Web | https://www.hawpar.com |
Haw Par Management Efficiency
Haw Par's management efficiency ratios could be used to measure how well Haw Par manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| David MD | Eli Lilly and | N/A | |
| Johannes Oosthuizen | Merck Company | 56 | |
| Mark Larkins | Johnson Johnson | N/A | |
| Pierre Chancel | Sanofi ADR | 68 | |
| Annette Doherty | Pfizer Inc | N/A | |
| Mikael MD | Pfizer Inc | 66 | |
| Elizabeth Shea | AbbVie Inc | N/A | |
| Roopal MD | AbbVie Inc | 53 | |
| Tom Cavanaugh | Johnson Johnson | N/A | |
| Susan Silbermann | Pfizer Inc | 63 | |
| Elizabeth Forminard | Johnson Johnson | 53 | |
| Jessica Moore | Johnson Johnson | N/A | |
| Hani Abouhalka | Johnson Johnson | N/A | |
| Nick Lagunowich | Pfizer Inc | N/A | |
| Cristina Wilbur | Roche Holding Ltd | 56 | |
| Elizabeth JD | Johnson Johnson | 54 | |
| Eric Dozier | Eli Lilly and | 57 | |
| Tracie Haas | AbbVie Inc | N/A | |
| Duane Arsdale | Johnson Johnson | N/A | |
| Gideon Blumenthal | Merck Company | N/A | |
| Eric MD | Merck Company | 64 | |
Management Performance
| Return On Equity | 0.0424 | |||
| Return On Asset | 0.0063 |
Haw Par Leadership Team
Elected by the shareholders, the Haw Par's board of directors comprises two types of representatives: Haw Par inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Haw. The board's role is to monitor Haw Par's management team and ensure that shareholders' interests are well served. Haw Par's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Haw Par's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Meng Kwek, Regional General Manager of Underwater World Singapore Pte Ltd / Haw Par Leisure Pte Ltd | ||
| Kun Chiew, Group Sec | ||
| Say Chow, Group Finance Controller | ||
| Ee Wee, CEO and President Director, Member of Investment Committee, CEO of Haw Par Healthcare Limited and Acting President of Haw Par Healthcare Limited | ||
| Mui Kow, Senior Manager-Quality & Regulatory Affairs of Healthcare | ||
| Tang Lee, Mang Communications | ||
| Tang Chow, Human Director | ||
| Brian Loo, Group Mang |
Haw Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Haw Par a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0424 | |||
| Return On Asset | 0.0063 | |||
| Profit Margin | 0.79 % | |||
| Operating Margin | 0.19 % | |||
| Current Valuation | (701.58 M) | |||
| Shares Outstanding | 55.34 M | |||
| Price To Earning | 21.33 X | |||
| Price To Book | 0.73 X | |||
| Price To Sales | 10.01 X | |||
| Revenue | 141.18 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Additional Tools for Haw Pink Sheet Analysis
When running Haw Par's price analysis, check to measure Haw Par's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Haw Par is operating at the current time. Most of Haw Par's value examination focuses on studying past and present price action to predict the probability of Haw Par's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Haw Par's price. Additionally, you may evaluate how the addition of Haw Par to your portfolios can decrease your overall portfolio volatility.